Flowcytometry/tc add-on
CPT 88185 is an add-on code for additional flow cytometry analysis performed on cells or tissue samples, typically used in diagnosing blood cancers, immune disorders, or monitoring transplant patients. This code is always billed with a primary flow cytometry code and cannot stand alone.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Always bill 88185 with appropriate primary flow cytometry code (88184, 88187, or 88188); never submit as standalone
Impact: Prevents automatic denial; standalone billing results in 100% claim rejection as 88185 is an add-on code only
Bill one unit of 88185 for each additional marker beyond those included in the primary code, with clear documentation of each marker analyzed
Impact: Proper unit billing can increase reimbursement by $22 per marker; underbilling loses an average of $88-$132 per complex immunophenotyping case
Document medical necessity for each additional marker with reference to specific diagnostic questions (e.g., lambda vs kappa light chain restriction, CD markers for lymphoma subtyping)
Impact: Reduces audit risk and denial rates by 60-75%; comprehensive documentation supports billing 6-12 add-on units for complex hematologic malignancy workups
Verify payer-specific limits on units per encounter; some commercial payers cap add-on codes at 10-15 units regardless of medical necessity
Impact: Prevents delayed denials and reduces appeal workload; proactive authorization for high-unit cases can secure payment for all units billed
Use diagnosis codes that specifically support flow cytometry (D89.9, C91.-, C82-85.-, D72.-, Z94.-) rather than generic symptom codes
Impact: Increases first-pass claim acceptance rate by 30-40%; specific ICD-10 codes justify comprehensive marker panels and higher unit counts
When billing for multiple specimens on same date, ensure specimen source and unique marker panels are clearly documented in report
Supports medical necessity for multiple primary codes with associated add-ons; can justify $200+ in additional reimbursement for multi-site biopsies
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.